Navigation Links
Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board
Date:12/15/2009

ed by microRNAs and mRNA within exosomes isolated from cancer patients. These genetic signatures created by the cancer exosomes could be critical in developing companion molecular diagnostics tests for tailoring personalized cancer therapy.

About Aethlon Medical

Aethlon Medical, Inc. creates diagnostic and therapeutic device solutions for infectious disease and cancer. Our lead product, the Hemopurifier® is the first-in-class medical device to selectively capture circulating viruses and immunosuppressive proteins prior to cell and organ infection. Human studies have documented the ability of our Hemopurifier® to reduce viral load in patients infected with Hepatitis-C virus (HCV) and the Human Immunodeficiency Virus (HIV). Our primary clinical and commercialization focus is to establish the Hemopurifier® as an adjunct therapy to enhance and prolong the benefit of traditional infectious disease drug regimens.

The Hemopurifier® is also a broad-spectrum treatment candidate against drug resistant bioterror and pandemic threats. Third party research institutes have verified the capability of the device to capture Dengue Hemorrhagic Virus, Ebola Hemorrhagic Virus, Lassa Hemorrhagic Virus, West Nile Virus, H5N1 Avian Influenza Virus, 2009 H1N1 Influenza Virus, the reconstructed Spanish Flu of 1918 Virus, and Monkeypox Virus, which serves as a model for human Smallpox infection.

Our wholly owned subsidiary, Exosome Sciences, Inc. (ESI) was formed in October of 2009 to leverage attributes of the Hemopurifier® in the emerging exosome research field. ESI seeks to inhibit the immune cell destruction caused by exosomes secreted by solid tumors, lymphomas, and leukemia. At present, the capture of immunosuppressive exosomes secreted from ovarian cancer tumors has been demonstrated invitro. The preservation of anti-cancer immune cells would likely improve patient responsiveness to established treatmen
'/>"/>

SOURCE Aethlon Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Aethlon Medical Announces Data Supported Strategy to Increase Hepatitis-C (HCV) Cure Rates
2. Aethlon Medical, Inc. Announces Annual Meeting Results
3. Aethlon Medical to Present at LD MICRO Conference on December 3, 2009
4. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
5. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
6. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
7. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
8. BioMS Medical announces its intention to renew a normal course issuer bid
9. Dr. Amit Dhawan Promoted to Medical Director for The Mattson Jack Group
10. ATS Medical Expands Open Pivot Heart Valve Offerings
11. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 22, 2015 Shimadzu Scientific Instruments ... multipurpose UV-visible spectrophotometer. Offering wavelength scanning from 190 ... ideal for applications in a variety of industries, ... The user-friendly UV-1280 enables intuitive operation, while the ...
(Date:1/22/2015)...  Transwestern | RBJ today announces the firm brokered a long-term ... a leading biopharmaceutical company, at Two Ledgemont Center in ... Richards , president, and Brian Cohen , senior vice ... building at 95 Hayden Ave. Photo - ...
(Date:1/22/2015)... Protocol Networks brings independent technology consulting ... brand-neutral, independent consultants, Protocol Networks has recently announced its ... the years, his company has attracted several clients in ... as well as others. With the success of these ...
(Date:1/22/2015)... 2015 zFlo Motion , a US ... an exciting product from a new partner. STT-Systems ... the past 15 years, with offerings in the optical-motion capture, ... IMU system (inertial measurement unit), iSen, is opening eyes around ...
Breaking Biology Technology:Shimadzu’s New Monitored Single-Beam UV-Vis Spectrophotometer Offers Comprehensive Measurement Options in a Compact Body 2Transwestern?RBJ Advises Shire in 202,000 SF Lease, Creating Boston's Largest Suburban Biotech Campus 2Protocol Networks Brings Independent Technology Consulting to the Constitution State 23D Motion Capture Just Got Easy 2
... 27 Soligenix, Inc., (Soligenix or the Company) (OTC ... a late-stage biotechnology company, announced today that its Chief ... highlighting recent developments at the BIO Investor Forum. , ... 2009 at 1:00 PM PDT at The Palace Hotel ...
... ... , ... October 27, 2009 -- Global food security, which is increasingly being recognized as a ... and private partnerships, William S. Niebur , vice president – DuPont Crop Genetics ...
... Cynosure, Inc. (Nasdaq: CYNO ), a leading developer and ... today announced financial results for the three and nine months ... Results , Revenues for the three months ended September ... the same period of 2008 and $20.8 million for the ...
Cached Biology Technology:Soligenix to Present at 8th Annual BIO Investor Forum 2Soligenix to Present at 8th Annual BIO Investor Forum 3Soligenix to Present at 8th Annual BIO Investor Forum 4Public-Private Partnerships Key to Achieving Global Food Security, Says DuPont Leader 2Public-Private Partnerships Key to Achieving Global Food Security, Says DuPont Leader 3Cynosure Reports Third Quarter 2009 Financial Results 2Cynosure Reports Third Quarter 2009 Financial Results 3Cynosure Reports Third Quarter 2009 Financial Results 4Cynosure Reports Third Quarter 2009 Financial Results 5Cynosure Reports Third Quarter 2009 Financial Results 6Cynosure Reports Third Quarter 2009 Financial Results 7Cynosure Reports Third Quarter 2009 Financial Results 8Cynosure Reports Third Quarter 2009 Financial Results 9Cynosure Reports Third Quarter 2009 Financial Results 10Cynosure Reports Third Quarter 2009 Financial Results 11Cynosure Reports Third Quarter 2009 Financial Results 12
(Date:12/17/2014)...  HITLAB SM announced today its completion of a ... to current U.S. Food and Drug Administration (FDA) regulations. ... and smart phone application trials utilizing the highest principles ... is determined to improve global healthcare access, quality, and ...
(Date:12/11/2014)... , Dec. 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition of ...  report to their offering. One major ... With continuous advances in technology, it is important to ...
(Date:12/10/2014)... N.C. , Dec. 9, 2014  Valencell, a leader ... is seeing a staggering demand from its licensees for ... Company revealed, is not solely coming from fitness and ... well. "A wearable is only as useful ...
Breaking Biology News(10 mins):HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wearable Technology Products Demand Highly Accurate Biometric Technology 2
... chase down speeding vehicles as the movie Jurassic Park would ... certainly no slouch, research out today suggests. The University ... running speeds of five meat-eating dinosaurs that varied in size ... study believed to be the most accurate ever produced ...
... BOSTON Ever since the Manhattan project in ... nuclear science and technology. Yet,scientists still seek the ... of actinide compounds and materials using first principle ... to achievement. PNNL scientist Jun Li will ...
... 2007) Genetic testing can be used to help ... according to research published in the September 1, 2007, ... American Society of Hematology. This result represents one of ... to guide personal medical care. Because individuals metabolize ...
Cached Biology News:T. rex quicker than Becks, say scientists 2Genetics determine optimal drug dose of common anticoagulant 2
... the translation boosting Cap 1 structure. mScript™ ... 40% to 80% capped using co-transcriptional systems) ... mScript™ also features the Cap 1 structure, ... to 50% more efficient in in vivo ...
...
Request Info...
... pPIC9K and pPIC3.5K vectors carry the kanamycin ... Reagent in Pichia. Spontaneous generation of multiple ... to increased levels of Geneticin Reagent. Pichia ... screened for their level of resistance to ...
Biology Products: